ESR1 and breast cancer: Further, in estrogen receptor (ER)-positive breast cancer, AhR signaling increased antiapoptotic x-linked inhibitor of apoptosis (XIAP) and superoxide dismutase type 1 in two cell lines, leading to apoptotic resistance [42].